v3.26.3
Stockholders’ Deficit (Tables)
12 Months Ended
Jun. 30, 2026
Stockholders’ Deficit [Abstract]  
Schedule of Common Stock Issued Upon Completion of the Reverse Recapitalization

The following table presents the number of the Company’s common stock issued upon completion of the Reverse Recapitalization:

 

    Shares of
Common
 
    Stock  
ACAC’s common stock outstanding prior to Reverse Recapitalization     3,971,634  
Less: redemption of ACAC’s common stock     (1,744,663 )
Common stock issued to underwriter     43,125  
Total common stock issued upon completion of the Reverse Recapitalization     2,270,096  
Schedule of Total Stock Based Compensation Expenses

The following table presents the total stock-based compensation expenses included in each of the respective expense line items for the periods presented: 

 

    For the Years Ended  
    June 30,  
    2026     2025  
             
Selling expenses   $ 307,458     $ 175,332  
General and administrative expenses     690,393       448,511  
Research and development expenses     263,703       191,835  
Total stock-based compensation expenses   $ 1,261,554     $ 815,678  
Schedule of Restricted Stock Units Granted

The following table summarizes the activity for all restricted stock units granted for the years ended Juen 30, 2026 and 2025:

 

    Shares     Weight
average
grant date
fair value
    Total fair
value
    Weighted
average  
remaining
contractual
term
(in years)
 
Unvested at July 1, 2024     -     $ -     $ -       -  
Granted     727,009       7.21       5,243,400       4.00  
Vested     -       -       -       -  
Forfeited     (33,080 )     7.30       (241,484 )     -  
Unvested at June 30, 2025     693,929       7.21       5,001,916       3.36  
Granted     -       -       -       -  
Vested     (260,595 )     7.22       (1,882,417 )     -  
Forfeited     (44,180 )     7.30       (322,514 )     -  
Unvested at June 30, 2026     389,154     $ 7.19     $ 2,796,985       2.36  
Schedule of Warrants Activity

The summary of warrants activity is as follows:

 

    Warrants
Outstanding
    Common
Stock
Issuable
    Weighted
Average
Exercise
Price
    Average
Remaining
Contractual
Life
 
June 30, 2024     -       -     $ -       -  
Granted     12,156,417       12,156,417     $ 11.50       5.00  
Forfeited     -       -     $ -       -  
Exercised     (10,500 )     (10,500 )   $ 11.50       -  
June 30, 2025     12,145,917       12,145,917     $ 11.50       4.24  
Granted     -       -     $ -       -  
Forfeited     -       -     $ -       -  
Exercised     -       -     $ -       -  
June 30, 2026     12,145,917       12,145,917     $ 11.50       3.24